Targeting KRAS Mutations in Pancreatic Cancer: Insights from Mouse
Models and Clinical Prospects
• Group Leader of Experimental Oncology Group, Molecular Oncology Program
• Spanish National Cancer Research Centre (CNIO), Madrid, Spain
• Pioneer in Cancer Research and Discoverer of the First Human Oncogene - HRAS
Improved CaP Nanoparticles for Nucleic Acid and Protein Delivery to
Neural Primary Cultures and Stem Cells
• Associate Professor. Department of Physiology, School of Medicine, Taipei Medical University.
• EMBO Global Investigator Network Award, Europe
• Outstanding Research Award, Taipei Medical University, Taiwan
15 Years of Chromatin Factor Research:
Lessons from HMGA Proteins and Future Horizons
• Emmy Noether Research Group Leader of Epigenetic Machineries and Cancer Research Group
• Founding Managing Director of PlexoA GmbH
AI-Powered HTS: Unlocking Precision in Hit Discovery
• Director, High-Throughput Screening at Southern Research.
• President, Academic Drug Discovery Consortium.
• Ph.D. in Analytical Chemistry from Emory University.
• Head of A.I. Drug Discovery at Southern Research.
• Ph.D. in Computational Chemistry from the University of Illinois Urbana-Champaign.
• Advisory member, Center for Clinical and Translational Science, University of Alabama at Birmingham.
Inflammation in Infection and Cancer: New Biological Insights and Emerging Therapeutics
• Professor of Immunology at the John Curtin School of Medical Research, The Australian National University
• CSL Centenary Fellow & NHMRC Leadership Fellow
Ex Vivo Drug Response Profiling in Clinical Application
• Resident Physician and Physician Scientist, University Hospital Düsseldorf
• Recipient of the Franziska-Kolb-Foundation Research Award
New Oncology Targets from Fragment Leads
• Head of Medicinal Chemistry, Sussex Drug Discovery Center
• Scientific Advisory Member (grant committee) Prostate Cancer UK
TGF-β Signaling and Organ Fibrosis
• In Pharmacology at the Centro de Investigación y de Estudios Avanzados (CINVESTAV-IPN) en México.
• Postdoctoral Research Associate at Thomas Jefferson University.
• American Heart Association Member.
• President- Thomas Jefferson University's Jefferson Postdoctoral Association.
- August 28, 2024 (Wednesday)
- 13:00 - 14:00 ET
- 12:00 - 13:00 CT
- 10:00 - 11:00 PT
- 19:00 - 20:00 CEST
Tissue-Specific Differences in The Induction of Type 2 Immunity are Controlled by Specialized Dendritic Cell Subsets
• Professor for Dermatological Immunotherapy, University Medical Center of the Johannes
Gutenberg-University Mainz
• Member of the Research Center for Immunotherapy, the Center for Healthy Ageing and the Institute
for Quantitative & Computational Bioscievvnces
Cellular Senescence in Cornelia de Lange Syndrome :
A Pharmacological Target?
• Research director at Inserm
• Team leader and senior researcher
Cancer Immunosuppression and How to Conquer it
• John M. and Mary Jo Boler Collegiate Associate Professor, University of Notre Dame
• Full Member of Tumor Microenvironment and Metastasis Program, Indiana University
Simon Comprehensive Cancer Center
30 Years in PI 3-kinase Research: Lessons Learned
and Looking to the Future
• Professor of Cell Signalling at the UCL Cancer Institute
• Elected member of EMBO and the UK Academy of Medical Sciences
Stressing Out Therapy Resistant Cancers
• Baylor College of Medicine Associate Professor
• Cullen Duncan McAshan Endowed Chair in Cancer Research
